Chenhe Yi

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 26, 2021
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.

Chenhe Yi, Lirong Chen, Zhifei Lin

Pageof 1

Frequent Collaborators

2 joint publications

Lirong Chen

2 joint publications

Jinhong Chen

1 joint publications

Zhifei Lin

1 joint publications

Lunxiu Qin